Market Overview:
Blepharitis is a chronic inflammation of the eyelids that leads to redness, irritation, itching and scaling of the eyelids. Products such as eyelid scrubs, warm compresses, eyelid wipes and other medicated creams and ointments are used to treat eyelid inflammation and remove debris and scales from eyelashes.
The global Blepharitis Treatment Market is estimated to be valued at US$ 2.5 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the blepharitis treatment market is the widespread adoption of hygiene-focused treatment regimens. Maintaining eyelid hygiene through regular warm compresses, eyelid scrubs and eyelid wipes has become the standard first line treatment for blepharitis. These hygiene products help remove debris, scales and bacteria from eyelids and lashes, providing relief from inflammation and irritation. Growing awareness about the role of hygiene in blepharitis management is driving the demand for various eyelid cleansing products.
Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/blepharitis-treatment-market-1761
SWOT Analysis
Strength: Blepharitis treatment products offer effective and long-lasting relief from the symptoms of blepharitis. They help clear debris, reduce redness and irritation, and control bacterial/fungal infections.
Weakness: Lack of awareness about blepharitis condition and available treatment options limits the sales potential of products in developing nations. Certain treatments require daily application which patients may find inconvenient.
Opportunity: Rising pollution levels and increased digital device usage have contributed to the increasing prevalence of blepharitis globally. Growing geriatric population also prompts the need for effective treatment measures.
Threats: Presence of alternative treatment methods like warm compresses, eyelid scrubs, and antibiotic/steroid eye drops poses competition. Entry of generic drug manufacturers impacts revenues of established players.
Key Takeaways
The global blepharitis treatment market is expected to witness high growth, exhibiting a CAGR of 10% over the forecast period, due to increasing awareness about various treatment options and rising pollution levels. North America currently dominates the market owing to large patient base and high healthcare spending in the region.
The global blepharitis treatment market size for 2023 is US$ 2.5 Bn. The market is anticipated to reach a value of over US$ 5.5 Bn by 2030, expanding at a steady rate. Rising pollution levels have significantly contributed to growing blepharitis prevalence globally. The increasing digital device usage has also been linked to higher blepharitis risk.
Key players operating in the blepharitis treatment market are Scope Ophthalmic Ltd., NovaBay Pharmaceuticals Inc., Thea Pharmaceuticals Ltd., Perrigo Laboratories, InSite Vision Incorporated, Merck & Co., and Novartis AG. These players are focused on developing innovative and effective products to expand their market share.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
